Royal Bank of Canada Analysts Give Reckitt Benckiser Group (LON:RB) a GBX 5,900 Price Target

Royal Bank of Canada set a GBX 5,900 ($77.09) price objective on Reckitt Benckiser Group (LON:RB) in a research report report published on Monday morning, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.

Several other brokerages have also recently issued reports on RB. Jefferies Financial Group raised AGCO from a hold rating to a buy rating and increased their target price for the company from $70.00 to $90.00 in a research report on Monday, June 24th. Morgan Stanley reaffirmed an overweight rating on shares of in a research report on Thursday, June 20th. Liberum Capital increased their target price on Moneysupermarket.Com Group from GBX 520 ($6.79) and gave the company a buy rating in a research report on Thursday, July 11th. HSBC set a $46.00 target price on Aqua America and gave the company a buy rating in a research report on Friday, June 28th. Finally, UBS Group cut Telstra from a buy rating to a neutral rating in a research report on Monday, July 1st. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of GBX 7,244.44 ($94.66).

Shares of LON RB opened at GBX 6,688 ($87.39) on Monday. The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47. The company has a market cap of $47.42 billion and a PE ratio of 21.94. The firm’s fifty day moving average is GBX 6,404.88. Reckitt Benckiser Group has a 12-month low of GBX 5,559 ($72.64) and a 12-month high of GBX 7,174 ($93.74).

In other news, insider Adrian Nevil Hennah sold 13,701 shares of the firm’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of GBX 6,143 ($80.27), for a total value of £841,652.43 ($1,099,767.97). Also, insider Christopher Sinclair bought 1,076 shares of Reckitt Benckiser Group stock in a transaction that occurred on Thursday, May 23rd. The stock was purchased at an average price of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Read More: What is a CD ladder?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.